Does Rallies show IBD price targets?

Yes. Rallies tracks IBD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is IBD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IBD. It does not provide personalized investment advice.

IBD (Inspire Corporate Bond ETF) Stock Analysis - Analyst Ratings

Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate IBD?

The average price target is $0.00.

IBD Key Metrics

Key financial metrics for IBD
Metric	Value
Price	$23.80
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	139.86K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

IBD Analyst Consensus

IBD analyst coverage data. Average price target: $0.00.

Latest IBD News

Inspire 500 ETF Hits $679.5M AUM with 30.55% Two-Year Return — Apr 22, 2026
Inspire Impact Group Ranks 42nd on Fastest-Growing Rocky Mountains List — Apr 1, 2026

Common questions about IBD

What do analysts rate IBD?: The average price target is $0.00.
Does Rallies show IBD price targets?: Yes. Rallies tracks IBD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is IBD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IBD. It does not provide personalized investment advice.